390 related articles for article (PubMed ID: 12627729)
1. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
Xyrem International Study Group
J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
[TBL] [Abstract][Full Text] [Related]
4. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
Mansukhani MP; Kotagal S
Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
[TBL] [Abstract][Full Text] [Related]
5. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
6. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
[TBL] [Abstract][Full Text] [Related]
7. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
Mamelak M; Black J; Montplaisir J; Ristanovic R
Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
Weaver TE; Cuellar N
Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
[TBL] [Abstract][Full Text] [Related]
9. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
10. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
Xyrem International Study Group
Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
[TBL] [Abstract][Full Text] [Related]
11. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
[TBL] [Abstract][Full Text] [Related]
12. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
Mamelak M; Swick T; Emsellem H; Montplaisir J; Lai C; Black J
Sleep Med; 2015 Jan; 16(1):52-8. PubMed ID: 25533539
[TBL] [Abstract][Full Text] [Related]
13. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
14. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
U.S. Xyrem Multicenter Study Group
Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130
[TBL] [Abstract][Full Text] [Related]
15. Criteria for gauging response to sodium oxybate for narcolepsy.
Steffen AD; Lai C; Weaver TE
J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
[TBL] [Abstract][Full Text] [Related]
16. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
17. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Bogan RK; Roth T; Schwartz J; Miloslavsky M
J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
[TBL] [Abstract][Full Text] [Related]
18. Sodium oxybate for cataplexy.
Lemon MD; Strain JD; Farver DK
Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
[TBL] [Abstract][Full Text] [Related]
19. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
